RXRX Stock Summary and Trading Ideas (Recursion Pharmaceuticals - Class A | NASDAQ:RXRX)

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.

What symbol and exchange does Recursion Pharmaceuticals - Class A shares trade?

Recursion Pharmaceuticals - Class A trades on the NASDAQ stock market under the symbol RXRX.

What is Recursion Pharmaceuticals - Class A stock price doing today?

As of July 2, 2026, RXRX stock price climbed to $3.80 with 31,301,902 million shares trading.

What is Recursion Pharmaceuticals - Class A's Beta?

RXRX has a beta of 2.45, meaning it tends to be more sensitive to market movements. RXRX has a correlation of 0.26 to the broad based SPY ETF.

How much is Recursion Pharmaceuticals - Class A worth?

RXRX has a market cap of $2.02 billion. This is considered a Mid Cap stock.

How much money does Recursion Pharmaceuticals - Class A make?

Last quarter Recursion Pharmaceuticals - Class A reported $6 million in Revenue and -$.22 earnings per share. This fell short of revenue expectation by $-9 million and exceeded earnings estimates by $.05.

What is the highest and lowest price Recursion Pharmaceuticals - Class A traded in the last 3 year period?

In the last 3 years, RXRX traded as high as $16.75 and as low as $2.77.

What are the top ETFs holding Recursion Pharmaceuticals - Class A?

The top ETF exchange traded funds that RXRX belongs to (by Net Assets): XBI, ARKK, VTI, ARKG, IWM.

Is Recursion Pharmaceuticals - Class A (RXRX) a good investment?

RXRX has underperformed the market in the last year with a return of -25.9%, while SPY returned +21.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in RXRX shares. However, RXRX has outperformed the market in the last 3 month and 2 week periods, returning +24.2% and +22.2%, while SPY returned +14.0% and +1.0%, respectively. This indicates RXRX has been having a stronger performance recently.

What are the support and resistance levels for Recursion Pharmaceuticals - Class A (RXRX)?

RXRX support price is $3.47 and resistance is $3.87 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RXRX shares will trade within this expected range on the day.